GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

This study is conducted in Asia, Europe and in the United States of America. The aim of this study is to examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Autoimmune Diseases Diabetes Mellitus Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Novo Nordisk Investigational Site, Beijing, Beijing Municipality, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

PATIENTS WITH DIABETES:
Age 18 years or older
Treated with insulin
Type 1 or Type 2 diabetes
PHYSICIANS:
In practice for more than 1 year since completing residency
See a minimum number of patients with diabetes per week (primary care physicians 5, specialists 10)
Initiate insulin treatment for patients with diabetes

Treatment and study plan

No treatment given

Behavioral

Survey conducted through computer-assisted telephone interviewing.

survey

Behavioral

Survey conducted via the Internet.

Primary outcomes

Frequency of insulin omission/non-adherence

Time frame: In the past 30 days prior to the day when responding to the survey (patient survey)
Reasons for insulin omission/non-adherence reported by patient and physician

Time frame: Day 1 (when responding to the survey)

Secondary outcomes

Impact of insulin treatment on life domains (patient survey)

Time frame: Day 1 (when responding to the online questionnaire)

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Sep 25, 2013
Registry last updated: Apr 27, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed